Halozyme Reports Q1 2026 Earnings with Strong Revenue Growth
Halozyme (HALO) reported first-quarter earnings for 2026, showing a significant increase in total revenue and royalty income. The company expects ENHANZE royalties to exceed $1 billion this year and raised its full-year revenue guidance.

Topics: buybacks ebitda eps revenue royalty_income